This inventor holds 1 USPTO granted patent. Top assignees: Ajinomoto General Foods, Inc., Intercontinental Great Brands LLC. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 9 
1 out of 313 Years Active: 2015
Title: Naoto Imura: Innovator in Pharmaceutical Composition
Introduction
Naoto Imura is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of lifestyle-related diseases. His innovative approach combines scientific research with practical applications, showcasing his dedication to improving health outcomes.
Latest Patents
Naoto Imura holds a patent for a pharmaceutical composition comprising mannooligosaccharides derived from coffee. This composition is designed for the prevention and treatment of lifestyle-related diseases. The active ingredient in this pharmaceutical composition is a sugar that contains 66% or more mannose units, with a polymerization degree ranging from 3 to 10. This innovative formulation aims to provide effective solutions for managing lifestyle-related health issues.
Career Highlights
Throughout his career, Naoto Imura has worked with prominent companies such as Ajinomoto General Foods, Inc. and Intercontinental Great Brands LLC. His experience in these organizations has allowed him to develop and refine his expertise in the pharmaceutical and food industries. His work has contributed to advancements in health-related products that benefit consumers.
Collaborations
Naoto has collaborated with esteemed colleagues, including Kazuto Ozaki and Ichiro Asano. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas. Together, they have worked on projects that aim to enhance the effectiveness of health-related products.
Conclusion
Naoto Imura is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the treatment of lifestyle-related diseases significantly. His innovative spirit and collaborative efforts with industry professionals highlight his commitment to advancing health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile